New #Diabetes Publication: GIP and GLP-1 Receptor Agonist for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. Read the results in NEJM: e.lilly/3xwDWqs

Why are patients with skin of color who have #AtopicDermatitis (AD) often diagnosed at more severe stages? Dr. Andrew Alexis highlights how racial and ethnic disparities and delays in care impact AD severity in these patients. Learn more here: e.lilly/4exVjba

New #Obesity Publication → Weight-reduction preferences among OBSERVE study participants with obesity or overweight: opportunities for shared decision-making Read the results in Endocrine Practice: e.lilly/45XOvQj #obesityresearch #obesitymedicine

New #Obesity Publication! Explore the results of the SURMOUNT-OSA Phase 3 Trial in NEJM: e.lilly/3LnoeBl #obesityresearch #obesitymedicine

#GITwitter Do you ask your patients with #CrohnsDisease about bowel urgency? Up to 87% of patients with Crohn’s disease experience bowel urgency. HCPs can learn more from Dr. Millie Long here: e.lilly/3W2hb6h

We are excited to join #NeuroTwitter in Philadelphia, Pennsylvania as we dive into the latest #neuroscience research at #AAIC24 Learn more: e.lilly/3W8Exag

Lilly Medical is headed to #AAIC24! Don’t miss out on our upcoming oral presentations as we explore the latest insights in #neuroscience research. Learn more here: e.lilly/4f73j3n

At #AAIC24, we will be discussing the future treatments for Alzheimer’s Disease. Join our presentation on ‘Tau and Other Non-Amyloid Targets’ on Sunday, July 28th at 9 AM ET. Learn more here: e.lilly/4faKyfh

#AAIC24 Attendees! Mark your calendars for Tuesday, July 30 at 8:00 AM ET for our presentation on ‘Insights from TRAILBLAZER-ALZ 2: Potential Clinical Translation.’ Learn more here: e.lilly/3WwTB2H

Thank you to all those in the Neuroscience community who joined us at #AAIC24! Visit the Lilly congress hub to see the research we presented at this year’s meeting: e.lilly/3ygvzjl

We are excited to be at #ADCES24 in the Crescent City of New Orleans, Louisiana! Visit Lilly Medical at Booth 347, where our team will be available to answer your questions. Learn More: e.lilly/3WHpBBq #Diabetes

Itching to learn about IL-13’s role in atopic dermatitis? Join Dr. Sarina Elmariah as she discusses the role of IL-13 in atopic dermatitis, including its impact on neuron sensitization and how it triggers itching. Learn more here: e.lilly/3VZ0fxp

Enhance patient care with effective lifestyle management for Type 2 Diabetes! Explore our free comprehensive tipsheet to guide your patients on the critical role of exercise and nutrition during weight reduction. Learn More: e.lilly/3YfCq7e

#GITwitter: IBD GAPPS survey reveals divergent patient and healthcare provider views on important Crohn's disease symptoms such as bowel urgency. HCPs can learn more from Dr. Long here: e.lilly/4dry80R

Understanding the burden of comorbidities, such as obesity, is important in the holistic management of patients with psoriatic arthritis and psoriasis. Click here to learn more: e.lilly/4fsuN3w #PsoriaticArthritis #Psoriasis

New publication in the Journal of Managed Care & Specialty Pharmacy: Health care resource utilization and direct costs incurred over 24 months after initiating a CGRP mAb or standard-of-care preventive migraine treatments. View full publication: e.lilly/4cmmaVp

Discussing novel Alzheimer’s disease treatments with patients can be challenging. In this video, Dr. Sharon Cohen shares topics to consider when initiating patients on amyloid targeting therapies. Visit e.lilly/4dnWUPX for the full video and more resources.

#SkinOfColorUpdate attendees! Join Dr. Andrew Alexis and Dr. Jill Waibel for a hands-on, clinical case discussion that explores atopic dermatitis in patients with diverse skin tones. Saturday, Sept. 14, at 9:00AM in the Gramercy Room. View agenda: e.lilly/3Wt1S6I

How is alopecia areata different from other forms of hair loss? Let’s hear from our expert, Dr. Chesahna Kindred, as she sheds light on the different types of alopecia. #AlopeciaAreataAwarnessMonth Learn more here: e.lilly/3WRV42C #AlopeciaAreata

We are excited to join you in Madrid, Spain at #EASD2024. Learn More: e.lilly/4gaHu3j #Diabetes #Obesity